DE69804998T2 - Mometasonfuroat-suspensionen zum zerstäuben - Google Patents

Mometasonfuroat-suspensionen zum zerstäuben

Info

Publication number
DE69804998T2
DE69804998T2 DE69804998T DE69804998T DE69804998T2 DE 69804998 T2 DE69804998 T2 DE 69804998T2 DE 69804998 T DE69804998 T DE 69804998T DE 69804998 T DE69804998 T DE 69804998T DE 69804998 T2 DE69804998 T2 DE 69804998T2
Authority
DE
Germany
Prior art keywords
furoat
mometason
suspensions
spraying
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69804998T
Other languages
English (en)
Other versions
DE69804998D1 (de
Inventor
David Harris
A Sequeira
A Chaudry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE69804998D1 publication Critical patent/DE69804998D1/de
Application granted granted Critical
Publication of DE69804998T2 publication Critical patent/DE69804998T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69804998T 1997-10-09 1998-10-06 Mometasonfuroat-suspensionen zum zerstäuben Expired - Lifetime DE69804998T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94811897A 1997-10-09 1997-10-09
PCT/US1998/020480 WO1999018971A1 (en) 1997-10-09 1998-10-06 Mometasone furoate suspensions for nebulization

Publications (2)

Publication Number Publication Date
DE69804998D1 DE69804998D1 (de) 2002-05-23
DE69804998T2 true DE69804998T2 (de) 2002-12-12

Family

ID=25487304

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69804998T Expired - Lifetime DE69804998T2 (de) 1997-10-09 1998-10-06 Mometasonfuroat-suspensionen zum zerstäuben

Country Status (8)

Country Link
EP (1) EP1033991B1 (de)
JP (1) JP3676674B2 (de)
AT (1) ATE216244T1 (de)
AU (1) AU9674398A (de)
CA (1) CA2305256C (de)
DE (1) DE69804998T2 (de)
ES (1) ES2172217T3 (de)
WO (1) WO1999018971A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
WO2003037317A1 (en) * 2001-10-26 2003-05-08 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US20050148563A1 (en) * 2003-09-26 2005-07-07 Schering Corporation Pulmonary disease treatment
ITMI20032054A1 (it) 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
EP1683514B1 (de) 2005-01-20 2012-05-23 Eratech S.r.l. Verfahren zur Herstellung konzentrierter Suspensionen und Kit davon
JP2009518300A (ja) * 2005-12-02 2009-05-07 エラン ファーマ インターナショナル リミテッド モメタゾン組成物ならびにその作製方法および使用方法
EP2394653A1 (de) 2010-05-26 2011-12-14 Almirall, S.A. Topische pharmazeutische Zusammensetzungen enthaltend Mometasonfuroat
ES2670025T3 (es) * 2014-09-15 2018-05-29 Verona Pharma Plc Formulación para inhalación líquida que comprende RPL554
WO2020070599A1 (en) * 2018-10-05 2020-04-09 Glenmark Specialty S.A. Nebulization composition of mometasone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065701T3 (es) * 1990-09-10 1995-02-16 Schering Corp Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.
CA2111003A1 (en) * 1991-06-10 1992-12-23 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

Also Published As

Publication number Publication date
AU9674398A (en) 1999-05-03
DE69804998D1 (de) 2002-05-23
ATE216244T1 (de) 2002-05-15
CA2305256C (en) 2005-05-17
JP3676674B2 (ja) 2005-07-27
EP1033991B1 (de) 2002-04-17
ES2172217T3 (es) 2002-09-16
EP1033991A1 (de) 2000-09-13
JP2001519397A (ja) 2001-10-23
WO1999018971A1 (en) 1999-04-22
CA2305256A1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
DE69804998T2 (de) Mometasonfuroat-suspensionen zum zerstäuben
MXPA04003754A (es) Metodo de perforacion de pozos y fluido de perforacion.
AU7105400A (en) Quaternary ammonium salts as thickening agents for aqueous systems
AU2002238472A1 (en) Aqueous, effect-producing coating material, method for the production thereof and use of the same
BR0104326B1 (pt) ôcomposição aquosa de revestimentoö.
EP1312356A4 (de) Wässerige suspensionszubereitungen
BR0014997B1 (pt) concentrado anticongelante, e, composição refrigerante aquosa.
WO2006065579A3 (en) Desizing process
DK1414956T3 (da) Höjt påvirkningsresistente granula
ES2174592T3 (es) Suspension homogenea estable desprovista de emulsionante, su procedimiento de preparacion y su utilizacion en unas composiciones alimenticias.
BR0013417B1 (pt) composiÇço aquosa.
WO2002024685A8 (fr) Derives de l'indole et leur utilisation en tant qu'agents antifongiques et/ou antiparasitaires
DE69937736D1 (de) Wässerige dispersionen für polyolefinsubstrate
CU23047A3 (es) Derivados de aminoacidos halogenados utiles como inhibidores de la oxido nitrico-sintasa.
UA89781C2 (uk) Рідкий склад гормона росту
ATA217399A (de) Wässriges überzugsmittel
BRPI0408252B1 (pt) uso de Ácidos poliacrÍlicos, e, suspensço aquosa finamente dividida de carbonato de cÁlcio.
HRP20010878B1 (en) Ziprasidone suspension
AU2769799A (en) Aqueous dispersions
DK1077976T3 (da) Vandopløselige azoler som bredspektrede antisvampemidler
BR0308170A (pt) Composição para limpeza lìquida aquosa, método para limpeza de um substrato, e, uso de um polioxometalato
BR9917305A (pt) Meio de recepção de tinta, conjunto de tinta/meio de recepção de tinta, e, processo de produção de um meio de recepção de tinta
AU2002248188A1 (en) Aqueous dispersions for coating compositions
HK1081216A1 (en) Aqueous coating agent based on epoxybutene polyethers
AR046634A1 (es) Una suspension fungicida acuosa concentrada

Legal Events

Date Code Title Description
8364 No opposition during term of opposition